Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

New drug helps treat pancreatic cancer

Digest more
Top News
Overview
 · 1d · on MSN
Revolution's pancreatic cancer drug doubles survival, boosts quality of life
(Corrects paragraph 5 to say "doubled" not "reduced") By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some patients could resume activities they had previously abandoned,

Continue reading

 · 11h
Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease
 · 1d · on MSN
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial
 · 18h
This Pancreatic Cancer Drug Is So Good, It Got a Standing Ovation
But over the weekend, a ballroom full of cancer specialists got to their feet to applaud a slide showing that Revolution Medicine’s daraxonrasib had doubled the survival time of patients with pancreat...

Continue reading

 · 1d
Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
 · 17h
Experimental pancreatic cancer drug shows promise in clinical trial
1don MSN

Revolution Medicines' new cancer pill extends life: ‘Molecular glue’ works, study shows

While the drug is not a cure, researchers say it could meaningfully improve both the length and quality of life for patients with advanced disease.
Healthline
1d

Groundbreaking New Drug Nearly Doubles Pancreatic Cancer Survival

Share on Pinterest An experimental new pill, daraxonrasib, significantly improved survival rates of participants with pancreatic cancer. Israel Sebastian/Getty Images A new medication performed remarkably well in a phase 3 clinical trial for treating ...
  • Privacy
  • Terms